Allergy Diagnostics Market Size is Projected To Reach USD 5510 Million By 2028 At A CAGR of 6.0% - Valuates Reports

BANGALORE, India, April 14, 2022 /PRNewswire/ -- Allergy Diagnostics market is segmented by Type - Kit, Instrument, by Application - food allergy, Skin sensibility, Childhood allergy, Other. Global Opportunity Analysis and Industry Forecast, 2021–2028.  It is published in Valuates Reports under the Allergies Category.

The global Allergy Diagnostics market size is projected to reach USD 5510 million by 2028, from USD 3563.9 million in 2021, at a CAGR of 6.0% during 2022-2028.

Major Factors Driving The Growth Of Allergy Diagnostics Market

The high prevalence of allergic diseases and the resulting high economic burden, rising levels of environmental pollution, increased funding for allergy diagnostics by organizations, and increased access to healthcare insurance are all expected to fuel the growth of the allergy diagnostics market.

Furthermore, allergies are becoming more prevalent in urban areas. As a result, a growing number of primary care physicians are offering or recommending allergy Diagnostics.

Browse The Table Of Contents And List Of Figures At https://reports.valuates.com/reports/QYRE-Auto-32W5928/global-allergy-diagnostics

TRENDS INFLUENCING THE GROWTH OF ALLERGY DIAGNOSTICS MARKET

Rising environmental pollution levels is expected to drive the growth of allergy diagnostics market. The main risk factors for chronic respiratory diseases are exposure to indoor and outdoor air pollutants, allergens, and occupational exposure. Because of the higher exposure to environmental pollutants in cities, the prevalence of allergic disorders among city dwellers is higher than among rural dwellers (as a result of vehicular pollution and industrial activities).

Increasing food allergy is expected to drive the allergy diagnostics market growth. Allergic diseases, such as food allergies, are more common in urban and first-world settings than in rural and third-world settings. The level of sanitation and risk of infectious disease is one of the most noticeable differences between these settings. Early life exposures to bacterial, viral, and parasitic infections, as well as exposure to a diverse population of normal human body microorganisms, are likely to influence immune system development.

Climate change, air pollution, and the growing complexity of materials and types of cosmetics have all contributed to an increase in the prevalence of sensitive skin and its potential for irritation. This, in turn, is expected to fuel allergy diagnostics market expansion. As scientists in the cosmetic industry became more aware of the phenomenon, they became more concerned about the development of anti-sensitive cosmetics.

Use of mHealth apps is expected to create lucrative growth opportunities for the  allergy diagnosis market. With only a few mHealth tools for allergic rhinitis (AR) diagnosis published in peer-reviewed journals, the use of mHealth for rhinitis diagnosis is currently limited. A new breed of point-of-care devices has emerged as a result of recent advancements in integrated biosensors, wireless communication, and power harvesting techniques.

End users (such as hospitals and diagnostic laboratories) and allergy diagnostic product manufacturers enter into reagent rental agreements. By entering into a reagent-purchase contract with the manufacturer, the end user rents or purchases instruments at a subsidized rate. This mutually beneficial agreement lowers the end user's initial capital investment while assuring the manufacturer of sales over a long period of time. Analyzers are sometimes rented out to end users on a cost-per-test basis.

The allergy diagnostics market's growth is expected to be hampered by the high costs associated with allergy diagnostic instruments.

Get Your Sample Today:  https://reports.valuates.com/request/sample/QYRE-Auto-32W5928/Global_Allergy_Diagnostics_Market

ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS

Based on region, North America is expected to be the most lucrative segment. The rising prevalence of allergies, favorable reimbursement scenarios for allergy diagnosis, and the availability of supportive initiatives by associations are all factors to consider.

Based on application,  Assay kits is expected to be the most lucrative segment. The large share of this segment can be attributed to assay kits' widespread availability, low cost, and widespread use in allergy testing.

Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-32W5928/Global_Allergy_Diagnostics_Market

Market By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-32W5928/Global_Allergy_Diagnostics_Market

Market By Company

• bioMerieux
• Thermo Fisher Scientific
• Danaher Corporation
• Omega Diagnostics
• Hitachi Chemical Diagnostics
• Stallergenes Greer
• Siemens Healthcare
• Lincoln Diagnostics
• Hycor Biomedical
• HOB Biotech Group
• Alcon Laboratories

Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-32W5928/Global_Allergy_Diagnostics_Market

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-32W5928&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

-  The global Influenza Diagnostics market size is projected to reach USD 3374.9 Million by 2027, from USD 2195.6 Million in 2020, at a CAGR of 6.3% during 2021-2027.

-  Due to the COVID-19 pandemic, the global Influenza Vaccine market size is estimated to be worth USD 8036 Million in 2022 and is forecast to a readjusted size of USD 10952 Million by 2028 with a CAGR of 5.3% during the review period

-  The global Allergy Diagnostics And Treatment market size is projected to reach USD 10150 million by 2028, from USD 6929 million in 2021, at a CAGR of 5.5% during 2022-2028.

-  The global Infectious Disease Diagnostics market size is projected to reach USD 4776.2 Million by 2027, from USD 3644 Million in 2020, at a CAGR of 4.3% during 2021-2027.

-  The global Allergy Diagnostics And Therapeutics market size is projected to reach USD 35890 million by 2027, from USD 27990 million in 2020, at a CAGR of 3.6% during 2021-2027.

-  The global Food Allergy market size is projected to reach USD 7 million by 2028, from USD 6 million in 2021, at a CAGR of 3.7% during 2022-2028.

-  Global Molecular Diagnostics Market was valued at USD 5,962 million in 2016, and is expected to garner USD 10,557 million by 2023, registering a CAGR of 9.1% during the forecast period 2017-2023.

-  Global Allergy Tester Market Insights and Forecast to 2028

-  Global Food Allergy Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027

-  Global Allergy Skin Test Market Insights and Forecast to 2028

-  Global Allergy Diagnostic Assay Kits Market Insights and Forecast to 2028

-  Global Ocular Allergy Diagnostic Systems Market Size, Status and Forecast 2021-2027

-  Global Allergy Immunotherapy Market Outlook 2022

-  Global Allergy Care Market Insights and Forecast to 2028

Click Here To See Related Reports on Allergy Diagnostics market

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com 
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg